Published in Nat Rev Microbiol on July 11, 2011
Collective nitric oxide production provides tissue-wide immunity during Leishmania infection. J Clin Invest (2014) 1.58
CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol (2013) 1.39
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog (2013) 1.28
Determinants for the development of visceral leishmaniasis disease. PLoS Pathog (2013) 1.22
IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog (2013) 1.15
Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function. J Immunol (2013) 1.14
Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species. J Infect Dis (2014) 1.09
Leishmania RNA virus: when the host pays the toll. Front Cell Infect Microbiol (2012) 1.08
Genomic confirmation of hybridisation and recent inbreeding in a vector-isolated Leishmania population. PLoS Genet (2014) 1.06
Mechanisms of immune evasion in leishmaniasis. Adv Appl Microbiol (2013) 1.04
Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia. PLoS Negl Trop Dis (2013) 1.04
Toll-like receptors in leishmania infections: guardians or promoters? J Parasitol Res (2012) 1.03
T cell exhaustion in protozoan disease. Trends Parasitol (2012) 1.01
An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis. J Clin Invest (2015) 1.01
IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasis. PLoS Pathog (2012) 1.00
Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia. PLoS Negl Trop Dis (2012) 0.99
Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis. Semin Immunopathol (2012) 0.98
Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol. J Lipid Res (2012) 0.97
Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression. PLoS Pathog (2012) 0.97
Induction of a stringent metabolic response in intracellular stages of Leishmania mexicana leads to increased dependence on mitochondrial metabolism. PLoS Pathog (2014) 0.95
Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology. J Invest Dermatol (2014) 0.94
Characterization of metabolically quiescent Leishmania parasites in murine lesions using heavy water labeling. PLoS Pathog (2015) 0.94
Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection. PLoS Pathog (2014) 0.94
Deception and manipulation: the arms of leishmania, a successful parasite. Front Immunol (2014) 0.93
Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen. PLoS Negl Trop Dis (2014) 0.93
Regulation of immunity during visceral Leishmania infection. Parasit Vectors (2016) 0.92
Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice. J Immunol (2013) 0.92
Participation of heparin binding proteins from the surface of Leishmania (Viannia) braziliensis promastigotes in the adhesion of parasites to Lutzomyia longipalpis cells (Lulo) in vitro. Parasit Vectors (2012) 0.91
Functional analysis of Leishmania cyclopropane fatty acid synthetase. PLoS One (2012) 0.91
Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival. J Antimicrob Chemother (2013) 0.91
Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunol (2014) 0.90
Leishmania mexicana metacaspase is a negative regulator of amastigote proliferation in mammalian cells. Cell Death Dis (2012) 0.90
Vaccine Development Against Leishmania donovani. Front Immunol (2012) 0.90
Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion. PLoS Pathog (2015) 0.89
Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages. Parasit Vectors (2013) 0.89
Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol (2016) 0.88
Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity. PLoS One (2013) 0.88
Absence of metalloprotease GP63 alters the protein content of Leishmania exosomes. PLoS One (2014) 0.87
CD4+ T Cells: guardians of the phagosome. Clin Microbiol Rev (2014) 0.87
Leishmaniasis in the middle East: incidence and epidemiology. PLoS Negl Trop Dis (2014) 0.86
Deletion of ubiquitin fold modifier protein Ufm1 processing peptidase Ufsp in L. donovani abolishes Ufm1 processing and alters pathogenesis. PLoS Negl Trop Dis (2014) 0.86
Iron in intracellular infection: to provide or to deprive? Front Cell Infect Microbiol (2013) 0.86
NLR proteins and parasitic disease. Immunol Res (2014) 0.86
Antileishmanial activity of diterpene acids in copaiba oil. Mem Inst Oswaldo Cruz (2013) 0.86
CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly. Semin Immunopathol (2015) 0.86
Mechanisms of cellular invasion by intracellular parasites. Cell Mol Life Sci (2013) 0.86
The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis. PLoS One (2016) 0.86
Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice. J Immunol (2012) 0.86
Lessons from other diseases: granulomatous inflammation in leishmaniasis. Semin Immunopathol (2015) 0.85
The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice. EMBO Mol Med (2012) 0.85
Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches. Front Immunol (2014) 0.85
Abortive T follicular helper development is associated with a defective humoral response in Leishmania infantum-infected macaques. PLoS Pathog (2014) 0.85
Immunoregulatory profile of monocytes from cutaneous leishmaniasis patients and association with lesion size. Parasite Immunol (2013) 0.84
Pathways of iron acquisition and utilization in Leishmania. Curr Opin Microbiol (2013) 0.83
Characteristics of "Tip-DCs and MDSCs" and Their Potential Role in Leishmaniasis. Front Microbiol (2012) 0.83
Role of protein kinase R in the killing of Leishmania major by macrophages in response to neutrophil elastase and TLR4 via TNFα and IFNβ. FASEB J (2014) 0.83
Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells. Parasite Immunol (2012) 0.83
LABCG2, a new ABC transporter implicated in phosphatidylserine exposure, is involved in the infectivity and pathogenicity of Leishmania. PLoS Negl Trop Dis (2013) 0.83
Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites. Chem Rev (2014) 0.83
The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis. Front Public Health (2014) 0.82
Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. MBio (2016) 0.82
Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications. Front Immunol (2014) 0.82
Innate immune activation and subversion of Mammalian functions by leishmania lipophosphoglycan. J Parasitol Res (2012) 0.82
Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis. PLoS Negl Trop Dis (2014) 0.82
Public Knowledge about and Detection of Canine Visceral Leishmaniasis in Urban Divinópolis, Brazil. J Trop Med (2012) 0.82
Functional Characterization of Monomeric GTPase Rab1 in the Secretory Pathway of Leishmania. J Biol Chem (2015) 0.81
Innate immunity against Leishmania infections. Cell Microbiol (2015) 0.81
The malnutrition-related increase in early visceralization of Leishmania donovani is associated with a reduced number of lymph node phagocytes and altered conduit system flow. PLoS Negl Trop Dis (2013) 0.81
Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions. BMC Genomics (2015) 0.81
Macrophage migration inhibitory factor in protozoan infections. J Parasitol Res (2012) 0.81
Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis. Hum Immunol (2013) 0.81
MHC class II restricted innate-like double negative T cells contribute to optimal primary and secondary immunity to Leishmania major. PLoS Pathog (2014) 0.81
Disuccinyl betulin triggers metacaspase-dependent endonuclease G-mediated cell death in unicellular protozoan parasite Leishmania donovani. Antimicrob Agents Chemother (2014) 0.81
A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis. J Clin Immunol (2014) 0.80
Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. Gene Ther (2015) 0.80
Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum. J Immunol (2015) 0.80
Blocking junctional adhesion molecule C enhances dendritic cell migration and boosts the immune responses against Leishmania major. PLoS Pathog (2014) 0.79
Changes in Macrophage Gene Expression Associated with Leishmania (Viannia) braziliensis Infection. PLoS One (2015) 0.79
Glycosome turnover in Leishmania major is mediated by autophagy. Autophagy (2014) 0.79
Blocking protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera. BMC Genomics (2012) 0.79
Tr-1-like CD4+CD25-CD127-/lowFOXP3- cells are the main source of interleukin 10 in patients with cutaneous leishmaniasis due to Leishmania braziliensis. J Infect Dis (2014) 0.79
The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis. Front Immunol (2016) 0.79
M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis. PLoS Negl Trop Dis (2015) 0.78
Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms. Immunol Res (2014) 0.78
Simultaneous infection with Leishmania (Viannia) braziliensis and L. (V.) lainsoni in a Peruvian patient with cutaneous leishmaniasis. Am J Trop Med Hyg (2013) 0.78
Generation of individual diversity: a too neglected fundamental property of adaptive immune system. Front Immunol (2014) 0.78
The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy. PLoS Negl Trop Dis (2015) 0.78
Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit Vectors (2016) 0.78
The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection. J Immunol (2014) 0.78
Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major. J Immunol (2015) 0.78
Intracellular Survival of Leishmania major Depends on Uptake and Degradation of Extracellular Matrix Glycosaminoglycans by Macrophages. PLoS Pathog (2015) 0.77
Do you see what I see: Recognition of protozoan parasites by Toll-like receptors. Curr Immunol Rev (2013) 0.77
Northalrugosidine is a bisbenzyltetrahydroisoquinoline alkaloid from Thalictrum alpinum with in vivo antileishmanial activity. J Nat Prod (2015) 0.77
New Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in Leishmaniasis. J Parasitol Res (2012) 0.77
Eosinophils and mast cells in leishmaniasis. Immunol Res (2014) 0.77
Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic properties. Hum Vaccin Immunother (2016) 0.77
Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach. EURASIP J Bioinform Syst Biol (2015) 0.77
Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection. Antimicrob Agents Chemother (2013) 0.77
Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes. BMC Immunol (2014) 0.77
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Development of monocytes, macrophages, and dendritic cells. Science (2010) 12.86
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med (2007) 11.80
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature (2002) 11.79
DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73
In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science (2008) 5.09
Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol (2007) 4.93
CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med (2007) 4.66
Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity (2007) 4.65
Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet (2007) 4.58
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med (2001) 3.63
Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector. Science (2009) 3.28
Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med (2004) 3.24
Arthropod-borne viruses transmitted by Phlebotomine sandflies in Europe: a review. Euro Surveill (2010) 2.78
Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med (2007) 2.75
Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps. Proc Natl Acad Sci U S A (2009) 2.68
The SIRP family of receptors and immune regulation. Nat Rev Immunol (2006) 2.57
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med (2005) 2.50
Interleukin-33 - cytokine of dual function or novel alarmin? Trends Immunol (2009) 2.40
Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature (2004) 2.36
CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol (2002) 2.16
Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Clin Infect Dis (2007) 2.08
A dynamic map of antigen recognition by CD4 T cells at the site of Leishmania major infection. Cell Host Microbe (2009) 1.92
Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog (2008) 1.90
Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science (2011) 1.88
Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J Immunol (1988) 1.87
Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes. Cell Microbiol (2010) 1.82
Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol (2001) 1.73
Neutrophil granulocytes--Trojan horses for Leishmania major and other intracellular microbes? Trends Microbiol (2003) 1.72
A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol (1999) 1.70
SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol (2001) 1.68
Macrophage interactions with neutrophils regulate Leishmania major infection. J Immunol (2004) 1.67
An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci (2010) 1.67
Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity (2008) 1.65
Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol Biochem Parasitol (2002) 1.65
IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol (2009) 1.63
Stromal cells direct local differentiation of regulatory dendritic cells. Immunity (2004) 1.58
Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol (1998) 1.58
CEACAM1+ myeloid cells control angiogenesis in inflammation. Blood (2009) 1.57
Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med (1997) 1.54
Fibroblasts as host cells in latent leishmaniosis. J Exp Med (2000) 1.54
iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog (2009) 1.53
Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol (2002) 1.44
Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur J Immunol (2006) 1.44
Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells. Infect Immun (1993) 1.43
Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol (2009) 1.43
Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection. J Immunol (2009) 1.41
Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection. J Leukoc Biol (2007) 1.35
Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol (2009) 1.34
Leishmania donovani promastigotes evade the antimicrobial activity of neutrophil extracellular traps. J Immunol (2010) 1.33
Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol (2004) 1.32
Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells. PLoS Pathog (2010) 1.32
Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. Sci Signal (2009) 1.32
Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J Immunol (2010) 1.32
Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med (2004) 1.31
Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol (2005) 1.28
B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections. PLoS Pathog (2009) 1.27
Leishmania-sand fly interactions controlling species-specific vector competence. Cell Microbiol (2001) 1.26
Stimulus-response coupling in monocytes infected with Leishmania. Attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. J Immunol (1992) 1.25
IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform. J Exp Med (2010) 1.23
The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J Biol Chem (2008) 1.22
Leishmaniasis Vaccine: Where are We Today? J Glob Infect Dis (2010) 1.22
Trafficking of Leishmania donovani promastigotes in non-lytic compartments in neutrophils enables the subsequent transfer of parasites to macrophages. Cell Microbiol (2007) 1.18
Hierarchical effector protein transport by the Salmonella Typhimurium SPI-1 type III secretion system. PLoS One (2008) 1.18
Identification of aerobic gut bacteria from the kala azar vector, Phlebotomus argentipes: a platform for potential paratransgenic manipulation of sand flies. Am J Trop Med Hyg (2008) 1.17
Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol (2009) 1.15
Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice. PLoS Pathog (2010) 1.14
Distribution and sequence divergence of LRV1 viruses among different Leishmania species. Mol Biochem Parasitol (1992) 1.13
The stage-regulated HASPB and SHERP proteins are essential for differentiation of the protozoan parasite Leishmania major in its sand fly vector, Phlebotomus papatasi. Cell Microbiol (2010) 1.13
Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J Immunol (2009) 1.13
The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V. PLoS Pathog (2009) 1.11
Vaccines for the leishmaniases: proposals for a research agenda. PLoS Negl Trop Dis (2011) 1.11
Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immunol (2001) 1.11
Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology (2005) 1.10
Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites. J Immunol (2010) 1.06
Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi. Infect Immun (2010) 1.06
Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol (2010) 1.04
Coiling phagocytosis of trypanosomatids and fungal cells. Infect Immun (1998) 1.02
IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection. J Immunol (2009) 1.00
Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania. FASEB J (2009) 1.00
Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell Microbiol (2006) 1.00
Iron acquisition within host cells and the pathogenicity of Leishmania. Cell Microbiol (2007) 0.99
Transcriptional signatures of BALB/c mouse macrophages housing multiplying Leishmania amazonensis amastigotes. BMC Genomics (2009) 0.99
Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7. PLoS Pathog (2010) 0.98
Leishmania parasitophorous vacuoles interact continuously with the host cell's endoplasmic reticulum; parasitophorous vacuoles are hybrid compartments. Cell Microbiol (2010) 0.97
Macrophage tolerance: CD47-SIRP-alpha-mediated signals matter. Nat Immunol (2007) 0.97
Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell Microbiol (2008) 0.96
NF-kappaB-mediated repression of iNOS expression in Leishmania amazonensis macrophage infection. Immunol Lett (2009) 0.96
Temperature increase prevails over acidification in gene expression modulation of amastigote differentiation in Leishmania infantum. BMC Genomics (2010) 0.95
A novel role for Stat1 in phagosome acidification and natural host resistance to intracellular infection by Leishmania major. PLoS Pathog (2009) 0.95
Proapoptotic Bcl-2 family member Bim promotes persistent infection and limits protective immunity. Infect Immun (2007) 0.94
CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection. J Immunol (2011) 0.94
A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome. Proc Natl Acad Sci U S A (2009) 0.94
Control of parasitophorous vacuole expansion by LYST/Beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathog (2008) 0.94
Leishmania donovani lipophosphoglycan inhibits phagosomal maturation via action on membrane rafts. Microbes Infect (2008) 0.93
Leishmania initially activates but subsequently down-regulates intracellular mitogen-activated protein kinases and nuclear factor-kappaB signaling in macrophages. Mol Immunol (2008) 0.92
Heme as a source of iron to Leishmania infantum amastigotes. Acta Trop (2008) 0.92
Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice. J Clin Invest (2010) 0.92
Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med (2004) 3.24
RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci U S A (2004) 3.05
TRAF6 is a critical factor for dendritic cell maturation and development. Immunity (2003) 2.36
The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J Immunol (2004) 2.09
Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog (2008) 1.90
Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophages. Parasite Immunol (2002) 1.80
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke (2008) 1.79
Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun (2002) 1.54
Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response. J Immunol (2004) 1.45
MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. J Exp Med (2004) 1.40
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J Exp Med (2007) 1.34
Persistence and function of central and effector memory CD4+ T cells following infection with a gastrointestinal helminth. J Immunol (2006) 1.33
Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med (2004) 1.31
Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation. J Immunol (2002) 1.31
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog (2013) 1.28
Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infect Immun (2005) 1.18
Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. J Immunol (2004) 1.16
Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. J Immunol (2003) 1.15
IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog (2013) 1.15
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Mol Cell Biol (2009) 1.13
Interleukin 17 production among patients with American cutaneous leishmaniasis. J Infect Dis (2009) 1.12
Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species. J Infect Dis (2014) 1.09
The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J Immunol (2003) 1.09
Cutting edge: NF-kappa B2 is a negative regulator of dendritic cell function. J Immunol (2004) 1.09
Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. J Immunol (2004) 1.08
The role of IL-12 in maintaining resistance to Leishmania major. J Immunol (2002) 1.07
The role of IL-27 in the development of T-cell responses during parasitic infections. Immunol Rev (2004) 1.06
STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major. J Immunol (2007) 1.05
The interaction of gamma delta T cells with activated macrophages is a property of the V gamma 1 subset. J Immunol (2003) 1.05
Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population. AJNR Am J Neuroradiol (2004) 1.01
IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection. J Immunol (2009) 1.00
Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection model. Vaccine (2003) 1.00
Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol (2002) 1.00
Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. J Immunol (2011) 1.00
Dendritic cell-intrinsic expression of NF-kappa B1 is required to promote optimal Th2 cell differentiation. J Immunol (2005) 0.97
NF-kappa B2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell Differentiation. J Immunol (2002) 0.97
NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major. J Immunol (2003) 0.96
The early generation of a heterogeneous CD4+ T cell response to Leishmania major. J Immunol (2010) 0.96
Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major. Infect Immun (2003) 0.95
The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma. J Immunol (2008) 0.94
Antigen-experienced T cells limit the priming of naive T cells during infection with Leishmania major. J Immunol (2006) 0.89
Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions. Infect Immun (2009) 0.89
Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice. Infect Immun (2006) 0.89
Activity of azithromycin against Leishmania major in vitro and in vivo. Am J Trop Med Hyg (2002) 0.87
Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation. J Immunol (2007) 0.87
Real-time assay for monitoring membrane association of lipid-binding domains. Anal Biochem (2008) 0.86
CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly. Semin Immunopathol (2015) 0.86
In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localization. J Immunol (2006) 0.85
UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major. J Biol Chem (2013) 0.85
Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke (2013) 0.84
Th1 cell-mediated resistance to cutaneous infection with Leishmania major is independent of P- and E-selectins. J Immunol (2003) 0.84
Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis. BMC Infect Dis (2013) 0.84
Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunity. J Immunol (2005) 0.84
Leishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infection. PLoS Negl Trop Dis (2012) 0.81
Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections. Infect Immun (2002) 0.77
Experimental Leishmania major infection suppresses HIV-1 DNA vaccine induced cellular immune response. Cells Tissues Organs (2004) 0.76
Memory T-cell subsets in parasitic infections. Adv Exp Med Biol (2010) 0.76
Influence of parasite load on the ability of type 1 T cells to control Leishmania major infection. Infect Immun (2002) 0.76
Correction: Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion. PLoS Negl Trop Dis (2017) 0.75